MERCAPTOPURINE
NDC 0054-0879, MERCAPTOPURINE, suspension, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0879
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216418
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0879 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MERCAPTOPURINE20 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0879-49 | 00054087949 | 1 BOTTLE, GLASS in 1 CARTON (0054-0879-49) / 100 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0a366cf3-91f0-4aa4-8f34-a7a27cad8f15
Use it
Look up 0054-0879 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0879 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0879. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.